ITM MEDICAL ISOTOPES - Trademark Details
Status: 700 - Registered
Serial Number
79295795
Registration Number
6383043
Word Mark
ITM MEDICAL ISOTOPES
Status
700 - Registered
Status Date
2021-06-15
Filing Date
2020-07-28
Registration Number
6383043
Registration Date
2021-06-15
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260113, 260121, 270301 - Two circles. Circles that are totally or partially shaded. Geometric figures forming letters or numerals, including punctuation.
Published for Opposition Date
2021-03-30
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
BHUPATHI, TARA LUISE
Statements
Disclaimer with Predetermined Text
"MEDICAL ISOTOPES"
Description of Mark
The mark consists of "ITM MEDICAL ISOTOPES" in stylized form with two circles emanating from the left corner of the "I" in "ITM" at a diagonal.
Goods and Services
Radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, in particular radiopharmaceutical preparations for endo-radionuclide therapy, brachytherapy and radiopharmaceutical preparations for positron emission tomography [PET] or single photon emission tomography [SPECT], target radionuclide and peptide receptor radionuclide therapy [PRRT]; theranostics in the field of precision oncology; radiopharmaceutical products, namely, lutetium-containing precursors for imaging and detection for diagnosing and monitoring cancer; solutions for radioactive labelling being medical diagnostic preparations; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceuticals containing radioisotopes, e.g. lutetium-177, actinium-225, yttrium-90 for treatment and radioisotopes such as gallium-68 or fluorine-18 for diagnosis of tumours; target radiopharmaceuticals containing a target molecule, e.g. peptide or antibody, depending on the indication and a medical radioactive isotope for diagnosis purposes; radiopharmaceuticals containing gallium and its complexes, gallium-68 DOTATOC for treatment of cancer; 177Lu-edotreotide preparations for targeted radionuclide therapy in patients with neuroendocrine tumours of gastroenteric or pancreatic origin [GEP-NET]; radiopharmaceuticals for use in the therapy of GEP-NET, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer; radiopharmaceuticals containing radioisotopes with short half-lives, such as gallium-68 or fluorine-18 for diagnostic applications; Radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as PET [positron emission tomography] or SPECT [single photon emission tomography], for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, in particular lutetium-177, actinium-225 or yttrium-90 for the treatment of tumour diseases
Goods and Services
Medical instruments, apparatus and containers for the application of radiopharmaceutical and radiodiagnostic preparations; controlling, regulating and measuring apparatus as parts of medical instruments, apparatus and containers included in this class, in particular apparatus for therapy and diagnosis with a radiotherapeutic or radiodiagnostic substance; radionuclide generators being medical instruments for radiopharmaceutical purposes
Goods and Services
Conducting clinical trials for others at all stages and in various indications, particularly in oncology; conducting phase III clinical trials for others with target radiopharmaceutical 177Lu-Edotreotide in patients with neuroendocrine tumours of gastroenteric or pancreatic origin [GEP-NET]
Goods and Services
Medical services, in particular services relating to radiotherapeutic and radiodiagnostic oncology, cardiology, angiology, neuroradiology and nuclear medicine and brachytherapies, including intercavitary, interstitial and intravascular brachytherapy, radionuclide labelling, PET and SPECT scanning and target radionuclide therapy, peptide receptor radionuclide therapy [PRRT], personal nuclear medicine and precision oncology
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-10-19
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2020-10-19
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-10-19
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-10-19
Primary Code
044
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
25
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
25
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
25
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
25
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Kari Moyer-Henry
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1555158
International Registration Date
2020-07-28
International Publication Date
2020-10-15
International Renewal Date
2030-07-28
Auto Protection Date
2022-04-15
International Status
001 - Request for extension of protection established
International Status Date
2020-10-15
Priority Claimed In
True
Priority Claimed Date
2020-02-20
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2020-10-15 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2020-10-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2020-10-23 | APPLICATION FILING RECEIPT MAILED |
| 2020-11-16 | ASSIGNED TO EXAMINER |
| 2020-11-19 | NON-FINAL ACTION WRITTEN |
| 2020-11-20 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2020-12-08 | REFUSAL PROCESSED BY MPU |
| 2020-12-08 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2020-12-27 | REFUSAL PROCESSED BY IB |
| 2021-02-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-02-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-02-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-02-12 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2021-02-12 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-02-12 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-02-12 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-02-12 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2021-02-23 | EXAMINERS AMENDMENT -WRITTEN |
| 2021-02-23 | EXAMINERS AMENDMENT E-MAILED |
| 2021-02-23 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2021-02-23 | EXAMINER'S AMENDMENT ENTERED |
| 2021-02-23 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-03-10 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-03-10 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2021-03-15 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2021-03-30 | PUBLISHED FOR OPPOSITION |
| 2021-03-30 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-04-05 | NOTIFICATION PROCESSED BY IB |
| 2021-06-15 | REGISTERED-PRINCIPAL REGISTER |
| 2021-09-15 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2021-09-30 | GENERIC MADRID TRANSACTION CREATED |
| 2021-09-30 | GENERIC MADRID TRANSACTION SENT TO IB |
| 2021-10-21 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2021-11-15 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2021-11-26 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
